Clinical Trial Update: Safety and Immunogenicity Study of Live Attenuated Vaccine Against Herpes Zoster in Chinese Adults Aged 50 Years and Older [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting safety and immunogenicity results of a live attenuated herpes zoster vaccine in Chinese adults aged 50 and older. The Phase 1/2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Snippet

Sponsor: Beijing Chaoyang District Centre for Disease Control and Prevention | Conditions: Herpes Zoster | Phase 1, Phase 2 | Status: COMPLETED